反応式
[NH:1]1[CH2:5][CH2:4][C@@H:3]([OH:6])[CH2:2]1.CCN(C(C)C)C(C)C.[Br:16][C:17]1[C:18](Cl)=[N:19][CH:20]=[C:21]([CH:36]=1)[C:22]([NH:24][C:25]1[CH:30]=[CH:29][C:28]([O:31][C:32]([Cl:35])([F:34])[F:33])=[CH:27][CH:26]=1)=[O:23].CCOC(C)=O>CC(O)C>[Br:16][C:17]1[C:18]([N:1]2[CH2:5][CH2:4][C@@H:3]([OH:6])[CH2:2]2)=[N:19][CH:20]=[C:21]([CH:36]=1)[C:22]([NH:24][C:25]1[CH:26]=[CH:27][C:28]([O:31][C:32]([Cl:35])([F:33])[F:34])=[CH:29][CH:30]=1)=[O:23]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
反応条件
- 温度
- 140 °C
実験手順
(R)-Pyrrolidin-3-ol (9.55 g, 109.6 mmol) and DIPEA (35.1 ml, 201.3 mmol) were added to a suspension of 5-bromo-6-chloro-N-(4-(chlorodifluoromethoxy)phenyl)nicotinamide (Stage 9.3, 37.7 g, 91.5 mmol) in iPrOH (65 mL) and stirred at 140° C. for 1 h. EtOAc (700 mL) was added and the solution was washed 1N HCl (2×200 mL), sat. NaHCO3 (200 mL) and brine (2×200 mL), dried over Na2SO4, and the solution was concentrated under reduced pressure until crystallization commenced. n-Heptane (1 L) were added and the mixture was stirred at RT for 30 min, filtered and washed with iPr2O (500 mL) to afford the title compound as a white crystalline solid. HPLC (Condition 5) tR=6.68 min, UPLC-MS (Condition 3) tR=1.10 min, m/z=462.2/464.2 [M+H]+; 1H-NMR (400 MHz, DMSO-d6) δ ppm 1.78-2.01 (m, 2H) 3.55 (d, J=11.34 Hz, 1H) 3.66-3.75 (m, 1H) 3.79-3.93 (m, 2H) 4.34 (br. s, 1H) 4.98 (d, =3.13 Hz, 1H) 7.32 (d, J=8.99 Hz, 2H) 7.84 (d, J=8.99 Hz, 2H) 8.33 (d, J=1.96 Hz, 1H) 8.66 (d, J=1.96 Hz, 1H) 10.21 (s, 1H).
後処理
- washthe solution was washed 1N HCl (2×200 mL), sat. NaHCO3 (200 mL) and brine (2×200 mL)
- dry with materialdried over Na2SO4
- concentrationthe solution was concentrated under reduced pressure until crystallization
- additionn-Heptane (1 L) were added
- stirringthe mixture was stirred at RT for 30 min
- filtrationfiltered
- washwashed with iPr2O (500 mL)
出典と根拠
- ORDレコード
- ord-b3144fc730da48c18153504df4b049c5
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08829195B2
関連ノート
読み込み中…